Executive Director, Healthcare Law and Market Access

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an Executive Director, Healthcare Law and Market Access reporting to the Vice President, Healthcare Law to join our RevMed team. The Executive Director, Healthcare Law and Market Access will serve as the zoldonrasib Legal brand lead and provide strategic legal guidance related to the company’s planned zoldonrasib commercialization activities, patient access programs, distribution and licensing, and regulatory submissions. In addition, the position will serve as the senior enterprise legal leader responsible for shaping and advancing Revolution Medicines’ U.S. Market Access legal strategy in support of commercialization, patient access, pricing, reimbursement, and corporate growth objectives. At a tactical level, the position will be responsible for managing all aspects of Market Access contracting through product distribution channels, including distributors, specialty distributors, specialty pharmacies, 3 rd party logistics providers and payers, and government pricing and reimbursement. A successful candidate will bring proven experience working at a publicly traded life sciences organization, with demonstrated success in driving legal cross-functional strategy. Serve as the zoldonrasib Legal brand lead for Commercial, Medical Affairs and other functions on a wide range of commercialization issues with broad enterprise impact Serve as the zoldonrasib Legal brand lead for Commercialization and Medical-related committees and teams, including promotional review, medical materials, and educational and charitable grants. Serve as counsel for healthcare regulatory law matters, including the FDCA and related Regulations, and Guidance Documents, fraud and abuse laws and guidances (Anti-Kickback Statute, False Claims Act, OIG Guidance and Advisory Opinions), and federal and state transparency and reporting laws. Provide legal counsel on regulatory interactions with FDA and other regulatory authorities. Coordinate with Compliance sub-function to operationalize compliance in commercialization activities, including related to promotional materials, scientific exchange, and interactions with HCPs. Serve as lead Market Access attorney for all RevMed products and provide strategic legal advice related to market access, pricing, reimbursement, price reporting and transparency and distribution via different channels and interest groups (e.g., specialty distributors, specialty pharmacies, PBMs, GPOs, 340B hospitals); potential to manage one Corporate Counsel, Market Access attorney in support of Market Access Contracting needs. Drive accountability for Market Access-related enterprise policy development, strategic governance frameworks, organizational risk strategy, and cross-functional commercialization infrastructure. Advise on issues regarding clinical trials, including related to CT.gov compliance, data privacy, interactions with clinical sites and investigators, CTA contracting and ICFs. Proactively monitor emerging healthcare and regulatory law trends, such as Biosecure, IRA, and MFN pricing, and assess and communicate their impact on RevMed. Build and manage teams in a dynamic high-growth environment. Required Skills, Experience and Education: JD degree with 1